Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
2.250
0.00 (0.00%)
Dec 27, 2024, 3:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $335.23 million as of December 27, 2024. Its market cap has decreased by -42.21% in one year.
Market Cap
335.23M
Enterprise Value
162.53M
Revenue
21.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.25
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 335.23M, a decrease of -37.73%. That is a compound annual growth rate of -10.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 27, 2024 | 335.23M | -50.09% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Veradigm | 1.60B |
SS Innovations International | 1.37B |
Elite Pharmaceuticals | 596.40M |
Nika Pharmaceuticals | 516.61M |
Glass House Brands | 425.90M |
Northwest Biotherapeutics | 359.81M |
Jun An Kang Group | 332.63M |
BioStem Technologies | 210.23M |